Literature DB >> 1937411

The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis.

R F Harrison1, S G Hubscher.   

Abstract

Tissue from 15 livers with primary sclerosing cholangitis, obtained at transplantation, was examined histologically with respect to: small and medium sized bile duct lesions; large bile duct lesions; fibrosis/cirrhosis; and parenchymal changes. Lesions affecting small and medium-sized bile ducts were quantified by determining the percentage of 20 portal tracts involved. The two characteristic bile duct lesions of primary sclerosing cholangitis, periductal fibrosis and fibro-obliterative scars, were largely confined to medium-sized portal areas. Although present in each case, the number of such lesions varied considerably. Loss of bile ducts was the most conspicuous feature in small portal tracts where the diagnostic duct lesions of primary sclerosing cholangitis were rarely observed. Inflammation, ulceration and cholangiectases of large intrahepatic ducts were common, and appear to be useful additional diagnostic features.

Entities:  

Mesh:

Year:  1991        PMID: 1937411     DOI: 10.1111/j.1365-2559.1991.tb00046.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.

Authors:  Laetitia Nguyen; Nora Cazzagon; Christophe Corpechot; Sanaâ El Mouhadi; Sara Lemoinne; Olivier Chazouillères; Lionel Arrivé
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

Review 2.  Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.

Authors:  Christoph Schramm; Ansgar W Lohse
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 3.  Liver biopsy in modern clinical practice: a pediatric point-of-view.

Authors:  Nadia Ovchinsky; Roger K Moreira; Jay H Lefkowitch; Joel E Lavine
Journal:  Adv Anat Pathol       Date:  2012-07       Impact factor: 3.875

4.  Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.

Authors:  Bojan D Petrovic; Paul Nikolaidis; Nancy A Hammond; John A Martin; Polina V Petrovic; Pankaja M Desai; Frank H Miller
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

5.  Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae.

Authors:  M C Pessolani; D R Smith; B Rivoire; J McCormick; S A Hefta; S T Cole; P J Brennan
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.